Larvol Delta - Poster-39CLK-inhibitor-BH30236-synergizes-with-venetoclax-in-antileukemia-activity-via-splicing-modulation-in-preclinical-AML-and-CLL-models39

BH-30236 - BlossomHill Therap

https://www.globenewswire.com/news-release/2026/04/22/3278800/0/en/BlossomHill-Therapeutics-Presents-First-Preclinical-Data-from-New-Pan-KRAS-Inhibitor-Program-Built-on-a-Novel-Chemical-Scaffold-During-Mini-Symposium-at-AACR-2026.html

Apr 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next